Leung SF - Search Results

1

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.

Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, Mo F, Lai M, Ho S, Huang DP, Johnson PJ. Chan AT, et al. Among authors: leung sf. J Natl Cancer Inst. 2002 Nov 6;94(21):1614-9. doi: 10.1093/jnci/94.21.1614. J Natl Cancer Inst. 2002. PMID: 12419787

2

Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients.

Chan KC, Zhang J, Chan AT, Lei KI, Leung SF, Chan LY, Chow KC, Lo YM. Chan KC, et al. Among authors: leung sf. Cancer Res. 2003 May 1;63(9):2028-32. Cancer Res. 2003. PMID: 12727814

3

Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.

Leung SF, Chan AT, Zee B, Ma B, Chan LY, Johnson PJ, Lo YM. Leung SF, et al. Cancer. 2003 Jul 15;98(2):288-91. doi: 10.1002/cncr.11496. Cancer. 2003. PMID: 12872347 Free article.

4

Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma.

To EW, Chan KC, Leung SF, Chan LY, To KF, Chan AT, Johnson PJ, Lo YM. To EW, et al. Among authors: leung sf. Clin Cancer Res. 2003 Aug 15;9(9):3254-9. Clin Cancer Res. 2003. PMID: 12960110

5

Disparity of sensitivities in detection of radiation-naïve and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2.

Leung SF, Lo YM, Chan AT, To KF, To E, Chan LY, Zee B, Huang DP, Johnson PJ. Leung SF, et al. Clin Cancer Res. 2003 Aug 15;9(9):3431-4. Clin Cancer Res. 2003. PMID: 12960133

6

Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody.

Leung SF, Tam JS, Chan AT, Zee B, Chan LY, Huang DP, Van Hasselt A, Johnson PJ, Lo YM. Leung SF, et al. Clin Chem. 2004 Feb;50(2):339-45. doi: 10.1373/clinchem.2003.022426. Epub 2003 Dec 18. Clin Chem. 2004. PMID: 14684618

7

Distribution of cell-free and cell-associated Epstein-Barr virus (EBV) DNA in the blood of patients with nasopharyngeal carcinoma and EBV-associated lymphoma.

Lit LC, Chan KC, Leung SF, Lei KI, Chan LY, Chow KC, Chan AT, Lo YM. Lit LC, et al. Among authors: leung sf. Clin Chem. 2004 Oct;50(10):1842-5. doi: 10.1373/clinchem.2004.036640. Epub 2004 Aug 19. Clin Chem. 2004. PMID: 15319320 No abstract available.

8

Investigation into the origin and tumoral mass correlation of plasma Epstein-Barr virus DNA in nasopharyngeal carcinoma.

Chan KC, Chan AT, Leung SF, Pang JC, Wang AY, Tong JH, To KF, Chan LY, Tam LL, Chung NY, Zhang J, Lo KW, Huang DP, Lo YM. Chan KC, et al. Among authors: leung sf. Clin Chem. 2005 Nov;51(11):2192-5. doi: 10.1373/clinchem.2005.054783. Clin Chem. 2005. PMID: 16244302 No abstract available.

9

Reduced plasma RNA integrity in nasopharyngeal carcinoma patients.

Wong BC, Chan KC, Chan AT, Leung SF, Chan LY, Chow KC, Lo YM. Wong BC, et al. Among authors: leung sf. Clin Cancer Res. 2006 Apr 15;12(8):2512-6. doi: 10.1158/1078-0432.CCR-05-2572. Clin Cancer Res. 2006. PMID: 16638860

10

Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma.

Leung SF, Zee B, Ma BB, Hui EP, Mo F, Lai M, Chan KC, Chan LY, Kwan WH, Lo YM, Chan AT. Leung SF, et al. J Clin Oncol. 2006 Dec 1;24(34):5414-8. doi: 10.1200/JCO.2006.07.7982. J Clin Oncol. 2006. PMID: 17135642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters